Equibles does not estimate personal net worth.
Get an email with a short summary when Fulcrum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FULC alertsIain Fraser has spoken on 1 earnings call across 1 company, most recently for Fulcrum Therapeutics, Inc. on April 27, 2026. Fulcrum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fulcrum Therapeutics, Inc. includes Alex C. Sapir (CEO and Board Member), Bryan Stuart (CEO, COO and Board Member), Robert J. Gould (CEO) and 7 others.
“I think you captured it very well, Alex. It's the severity of the disease and the manifestations experienced by these patients coupled with the really high unmet need in terms of available therapies for the patients.”
Source not stated
Biotechnology · Healthcare
